Lowering LDL-c and CV risk with new evidence-based non-statin treatment
This video was recorded at the Congress of the American College of Cardiology (ACC) 2023 in New Orleans, LA, USA.
Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School.
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS.
Read our summary of the CLEAR Outcomes trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: